about
Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptionsOngoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsEradicating HIV-1 infection: seeking to clear a persistent pathogen.The Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy).Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral TherapyDefining HIV and SIV Reservoirs in Lymphoid Tissues.Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive updateEradication of HIV and Cure of AIDS, Now and How?HIV eradication: combinatorial approaches to activate latent viruses.Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control.Mechanisms of HIV persistence in HIV reservoirs.Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.[Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND).Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA.Total HIV DNA: a global marker of HIV persistence.
P2860
Q26777442-464D837D-3CE1-4B63-9A52-62D14A2C08C5Q28079455-E2C706C5-85B4-4098-9280-4A7102339FC6Q35252186-896461EA-CF93-4CFC-871E-FC161EBF3B36Q36080407-EEB354C0-A993-4940-99B7-DE656FBB4272Q36950847-C460DBEA-9E12-44AB-B4F3-19FF5C13186EQ37090999-53C4E2F1-713A-4D02-8691-3CD1FABC0064Q37415458-DFA1744A-A6D5-4232-8344-607ACA43FE71Q37649116-70C5C9B3-F851-4379-BD8E-A80520EF67BDQ38154888-C103DA67-8723-4D37-B710-6B04ED803F0BQ38271132-67C77495-E865-417C-BB69-4A0507B3725AQ38737586-DCF776D8-4FF9-4EBA-B442-2A1B02D19F8EQ39106572-64415798-F6D8-4AD6-9914-81434FA7F7C1Q39315697-BF2B1719-D514-467E-9BD1-72CA275F48BDQ40375858-4D9C5615-C65D-4BCF-B762-FDEAC329E8BBQ40869409-373C3A99-6AFA-43DB-B1B3-D3BEE25E6CB6Q46531545-E5B1B729-A5AA-4967-818D-144699D946B8Q47549310-16A5E2F3-02E2-4CCF-BBAF-97D6795CB6CBQ54242626-D6E84A88-6B7B-4D5E-86B0-95EBBCF7B903
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How to best measure HIV reservoirs?
@en
How to best measure HIV reservoirs?
@nl
type
label
How to best measure HIV reservoirs?
@en
How to best measure HIV reservoirs?
@nl
prefLabel
How to best measure HIV reservoirs?
@en
How to best measure HIV reservoirs?
@nl
P2860
P1476
How to best measure HIV reservoirs?
@en
P2093
Douglas Richman
P2860
P304
P356
10.1097/COH.0B013E32835FC619
P577
2013-05-01T00:00:00Z